M.Sc

ImmunoGen is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its proprietary antibody-drug conjugate (ADC) technology. ImmunoGen’s lead product candidate, mirvetuximab soravtansine, is being advanced to a Phase 3 trial for FRα-positive platinum-resistant ovarian cancer, and is in Phase 1b/2 testing in combination regimens for earlier-stage disease. ImmunoGen’s ADC technology is used in Roche's marketed product, Kadcyla, in three other clinical-stage ImmunoGen product candidates, and in programs in development by partners Amgen, Bayer, Biotest, CytomX, Lilly, Novartis, Sanofi and Takeda.

Post : PATENT AGENT/ SR. PATENT AGENT

Clinical Development Services Agency (CDSA) has therefore been formed as a not-for-profit society to provide supportive and focused environment to host world class clinical translation through a collaborative network of clinical investigators and premier research institutions.  It will tend enterprises, particularly SMEs involved in new technology innovation, to facilitate translation of scientific know-how into viable products for public health diseases like malaria, tuberculosis and dengue among others.

Post : Senior Research Officer (Zinc Sepsis Study)

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Associate Scientist 1

A Walk-in-Interview will be held in the office of the Director, School of Oceanographic Studies, Jadavpur University, Kolkata 700032, on 03^rd January, 2018 (Wednesday) at 12 pm for the following position to carry on research work in the NRSC, Gol sponsored Project entitled, “STUDY OH CARBON DYNAMICS IN ESTURAIES AND NEARSHORE WATERS OF IIUGLI ESTUARY” under the supervision of Prof Sugata Hazra, Principal Investigator, School of Oceanographic Studies, Jadavpur University.

Post : Senior Research Fellow

Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.DNDi focuses on discovering and developing treatments for sleeping sickness (human African trypanosomiasis), Chagas disease, leishmaniasis, filarial infections, paediatric HIV, mycetoma, and hepatitis C. In 2016, in collaboration with the World Health Organization, DNDi launched the Global Antibiotic Research & Development Partnership, a not-for-profit research and development organization to develop new antibiotic treatments addressing antimicrobial resistance and to promote their responsible use for optimal conservation, while ensuring equitable access for all.

Post : Business Development Senior Manager

The North Maharashtra University, Jalgaon, established on 15th August, 1990 under the Maharashtra Universities Act, XXIX of 1989, started its academic and administrative functioning from the academic year 1991-92. Within the span of 3 years, the University is recognized under section 2 (f) in 1991 and 12 (B) in 1994 under the University Grants Commission (UGC) Act, 1956. The jurisdiction of the University is extended over three districts i.e. Jalgaon, Dhule and Nandurbar, a pre-dominantly tribal and rural area of Khandesh region. The University has opened it’s doors of higher education to mostly “first generation learners” of this area. Access, equity and academic excellence are the thrust areas of the University’s educational endeavor. Presently, Prof. P. P. Patil is the Vice-Chancellor. Following Vice-Chancellors have successfully shouldered the responsibility of the University in the past.

Our client is a fast growing pharma co. headquartered in Mumbai with its plant located Murbad, Maharashtra

Post : QC Manager

Biological E Ltd is a leading global vaccine & pharmaceutical company which provides affordable immunization and medicines across the world. It has current turnover of around Rs.1100 crore and employee strength of around 2000. It is growing at around 36% CAGR. Its intellectual pool of experienced scientist are based out of India and France. BE has state-of-the-art manufacturing sites in India (Hyderabad and Dehradun).

Post : Executive

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : POP and Grants Governance Lead